Lb Pharmaceuticals Common Stock Analysis
| LBRX Stock | 23.34 1.01 4.15% |
Short and Long Term Debt Total is likely to drop to about 3.2 M in 2026. Net Debt is likely to rise to about (16.5 M) in 2026 With a high degree of financial leverage come high-interest payments, which usually reduce LB Pharmaceuticals' Earnings Per Share (EPS).
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.13 | Current Value 0.12 | Quarterly Volatility 0.43982178 |
LB Pharmaceuticals Common is overvalued with Real Value of 17.85 and Hype Value of 21.99. The main objective of LB Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what LB Pharmaceuticals Common is worth, separate from its market price. There are two main types of LB Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The LB Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. LB Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. LBRX Stock trading window is adjusted to America/New York timezone.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LB Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. LBRX Stock Analysis Notes
The company had not issued any dividends in recent years. To find out more about LB Pharmaceuticals Common contact Heather JD at 212 605 0300 or learn more at https://lbpharma.us.LB Pharmaceuticals Common Investment Alerts
| LB Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| LB Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (63.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LB Pharmaceuticals generates negative cash flow from operations | |
| LB Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 |
LBRX Largest EPS Surprises
Earnings surprises can significantly impact LB Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-06 | 2025-09-30 | -0.28 | -0.61 | -0.33 | 117 |
LBRX Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.16) | (2.06) | |
| Return On Capital Employed | (2.93) | (2.79) | |
| Return On Assets | (2.16) | (2.06) | |
| Return On Equity | 0.60 | 0.36 |
Technical Drivers
As of the 14th of February 2026, LB Pharmaceuticals owns the Market Risk Adjusted Performance of (0.97), standard deviation of 5.21, and Mean Deviation of 3.91. In connection with fundamental indicators, the technical analysis model lets you check timely technical drivers of LB Pharmaceuticals Common, as well as the relationship between them.LB Pharmaceuticals Common Price Movement Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Extended Parabolic SAR indicator is used to determine the direction of LB Pharmaceuticals's momentum and the point in time when it has higher than normal probability of directional change. It has more input parameters than standard Parabolic SAR indicator.
LB Pharmaceuticals Outstanding Bonds
LB Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LB Pharmaceuticals Common uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LBRX bonds can be classified according to their maturity, which is the date when LB Pharmaceuticals Common has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US50187TAF30 Corp BondUS50187TAF30 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
LB Pharmaceuticals Predictive Daily Indicators
LB Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LB Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 8036.64 | |||
| Daily Balance Of Power | (0.90) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 23.84 | |||
| Day Typical Price | 23.67 | |||
| Price Action Indicator | (1.01) | |||
| Period Momentum Indicator | (1.01) |
LB Pharmaceuticals Forecast Models
LB Pharmaceuticals' time-series forecasting models are one of many LB Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary LB Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.LB Pharmaceuticals Bond Ratings
LB Pharmaceuticals Common financial ratings play a critical role in determining how much LB Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for LB Pharmaceuticals' borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (6.39) | Unlikely Manipulator | View |
LB Pharmaceuticals Total Assets Over Time
LB Pharmaceuticals Assets Financed by Debt
The debt-to-assets ratio shows the degree to which LB Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.LB Pharmaceuticals Debt Ratio | 12.0 |
LB Pharmaceuticals Corporate Bonds Issued
LBRX Short Long Term Debt Total
Short Long Term Debt Total |
|
About LBRX Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how LB Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling LBRX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as LB Pharmaceuticals. By using and applying LBRX Stock analysis, traders can create a robust methodology for identifying LBRX entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding LB Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Additional Tools for LBRX Stock Analysis
When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.